RAFAEL HOLDINGS, INC. Proceeds from Issuance or Sale of Equity
RAFAEL HOLDINGS, INC. (RFL) reported Proceeds from Issuance or Sale of Equity of $98.00 million for the 3-month period ending 2023-10-31, per its 10-Q filed 2023-12-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2025-10-29
- RAFAEL HOLDINGS, INC. proceeds from issuance or sale of equity for the quarter ending 2023-10-31 was $98.00M.
- RAFAEL HOLDINGS, INC. proceeds from issuance or sale of equity for the quarter ending 2019-07-31 was $0.00.
- RAFAEL HOLDINGS, INC. proceeds from issuance or sale of equity for the quarter ending 2019-04-30 was $0.00.
- RAFAEL HOLDINGS, INC. proceeds from issuance or sale of equity for fiscal 2023 was $98.00M.
- RAFAEL HOLDINGS, INC. proceeds from issuance or sale of equity for fiscal 2019 was $7.78M.
| Period end | Proceeds from Issuance or Sale of Equity | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 9 month | Proceeds from Issuance or Sale of Equity 12 month |
|---|---|---|---|---|---|
| 2023-10-31 | $98.00M 10-Q · filed 2023-12-14 | ||||
| 2023-07-31 | $98.00M 10-K · filed 2023-10-30 | ||||
| 2021-08-19 | $98.00M 10-K · filed 2025-10-29 | ||||
| 2019-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-04 | $0.00 derived: sum of 2 quarters · filed 2020-06-09 | $7.78M 10-K · filed 2019-10-04 | ||
| 2019-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-09 | $7.78M 10-Q · filed 2020-06-09 | |||
| 2019-01-31 | $7.78M 10-Q · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |